| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $141.2M | — | +14.3% |
| Cost of Revenue | $31.9M | — | +3.1% |
| Gross Profit | $109.3M | — | +18.0% |
| R&D Expense | $24.2M | — | +7.6% |
| SG&A Expense | $84.5M | — | +11.2% |
| Operating Income | $526K | — | +108.8% |
| Pre-tax Income | $394K | — | +106.1% |
| Income Tax | $286K | — | +19.7% |
| Net Income | $108K | — | +101.6% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $146.2M | -12.7% | +46.3% |
| Accounts Receivable | $71.3M | +7.0% | +12.6% |
| Inventory | $81.1M | +3.4% | +8.3% |
| Current Assets | $313.7M | -2.7% | +24.7% |
| Total Assets | $644.0M | -1.6% | +8.8% |
| Current Liabilities | $73.2M | -10.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.0M | — | +63.8% |
| Capital Expenditures | $3.9M | — | +76.6% |
| Investing Cash Flow | -$3.9M | — | -129.1% |
| Financing Cash Flow | -$13.3M | — | -28.4% |
| Free Cash Flow | -$7.8M | — | +40.6% |
| +19.6% |
| Long-term Debt | $61.0M | -1.4% | -1.4% |
| Total Liabilities | $152.3M | -6.1% | +11.2% |
| Stockholders' Equity | $491.7M | -0.0% | +8.2% |